ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Case report: A combined immunotherapy strategy as a promising therapy for MSI-H colorectal carcinomas with multiple HPD risk factors

Zhang, Jinli; Yang, Lu; Kong, Fanwei; Wu, Di; Hu, Baoru; Yang, Jie; He, Jiaxin; Liu, Lei*哈尔滨医科大学
Frontiers in Medicine2023-5-4DOI: 10.3389/fmed.2023.1051034
9阅读
引用收藏
分享

摘要

Approximately 5% of advanced colorectal carcinomas (CRCs) and 12-15% of early CRCs are microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) tumors. Nowadays, PD-L1 inhibitors or combined CTLA4 inhibitors are the major strategies for advanced or metastatic MSI-H colorectal cancer, but some people still show drug resistance or progression. Combined immunotherapy has been shown to expand the benefit population in non-small-cell lung carcinoma (NSCLC), hepatocellular carcinoma (HCC), and other tumors while reducing the incidence of hyper-progression disease (HPD). Nevertheless, advanced CRC with MSI-H remains rare. In this article, we describe a case of an elder patient with MSI-H advanced CRC carrying MDM4 amplification and DNMT3A co-mutation who responded to sintilimab plus bevacizumab and chemotherapy as the first-line treatment without obvious immune-related toxicity. Our case provides a new treatment option for MSI-H CRC with multiple risk factors of HPD and highlights the importance of predictive biomarkers in personalized immunotherapy.

学科与关键词

关键词
colorectal carcinomaMSI-HimmunotherapychemotherapyHPD
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2023-05-04
卷期
第 10 卷
页码
1051034
DOI
10.3389/fmed.2023.1051034
成果收录
SCIE

作者

  • Z

    Zhang, Jinli (第一作者)

    harbin med univ

  • Y

    Yang, Lu

查看全部 8 位作者收起作者
  • K

    Kong, Fanwei

    heilongjiang prov hosp

  • W

    Wu, Di

    harbin med univ

  • H

    Hu, Baoru

    harbin med univ

  • Y

    Yang, Jie

  • H

    He, Jiaxin

  • L

    Liu, Lei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417